Synopsis:
Take Solutions Limited, a Chennai-based life sciences and supply chain technology firm, delivers clinical, regulatory, safety, and supply chain solutions globally. It has shown strong growth and profitability recently, with a 192% stock rise in three months, highlighting its market momentum and investor interest.
Known for its expertise in life sciences and supply chain management technology, this company has delivered exceptional growth through innovative clinical and regulatory solutions. Investors are now eyeing it closely as the stock has soared 192 percent in the past three months, signaling strong market momentum.
Take Solutions Limited‘s stock, with a market capitalisation of Rs. 451 crores, rose to Rs. 30.53, hitting the intraday upper circuit, up 5 percent from its previous closing price of Rs. 29.08. Furthermore, the stock over the past 3 months has given a return of 192 percent.
Q2 FY26 Result
The company reported no operating revenue in Q2 FY26, the same as in Q2 FY25. It had earned Rs. 0.04 crore in Q1 FY26, showing very limited business activity during the September quarter.
In Q2 FY26, Take Solutions Limited posted a consolidated net profit of Rs. 6.29 crore, compared to a net loss of Rs. 1.58 crore in Q2 FY25. The company also turned profitable from a net loss of Rs. 0.91 crore in Q1 FY26. In Q2 FY26, Take Solutions Limited recorded a net profit mainly driven by gains from the discontinued operations of its wholly owned subsidiary, Ecron Acunova Limited (EAL).
Ratio Analysis
The company reports a Return on Capital Employed (ROCE) of around 21.32% and a Return on Equity (ROE) of approximately 15.55%. It has an earnings per share (EPS TTM) of Rs. 0.27 and remains debt-free with no outstanding borrowings.
The company currently trades at a P/E ratio of 114, compared with the industry average of 46.8. Over the past three years, it has recorded a 27% compound annual growth rate in profit but a 66% decline in return on equity (ROE) CAGR.
Company Overview
Take Solutions Limited, founded in 2000 and based in Chennai, is a global technology company focused on the Life Sciences and Supply Chain Management sectors. It uses deep industry knowledge and advanced technology to deliver end-to-end clinical, regulatory, safety, and supply chain solutions.
The company’s life sciences business offers complete Clinical Research Organization (CRO) services, such as clinical trials, bioavailability and bioequivalence studies, regulatory support, and drug safety monitoring. In supply chain management, it provides engineering, collaboration, and process automation services through its proprietary technology platform.
Take Solutions works with clients across the pharmaceutical, biotech, medical device, and generic drug industries. Its operations extend across India, the United States, Europe, and other global markets, supported by specialized expertise and delivery centers.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Multibagger Returns: Microcap stock that delivered 192% in the last 3 months to keep an eye on appeared first on Trade Brains.